Cleared Traditional

K832793 - NEOCATH 1000 W/HEPCOTE

K832793 is an FDA 510(k) clearance for NEOCATH 1000 W/HEPCOTE, manufactured by Orange Medical Instruments, Inc.. The device is a Class 2 Anesthesiology device with product code CCE cleared through the Traditional 510(k) pathway after a 38-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1983
Decision
38d
Days
Class 2
Risk

K832793 is an FDA 510(k) clearance for the NEOCATH 1000 W/HEPCOTE. Classified as Analyzer, Gas, Oxygen, Partial Pressure, Blood-phase, Indwelling (product code CCE), Class II - Special Controls.

Submitted by Orange Medical Instruments, Inc. (Walker, US). The FDA issued a Cleared decision on September 26, 1983 after a review of 38 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1200 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K832793

510(k) Number K832793 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 19, 1983
Decision Date September 26, 1983
Days to Decision 38 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
102d faster than avg
Panel avg: 140d · This submission: 38d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCE Device Classification - Class 2, Special Controls

Product Code CCE Analyzer, Gas, Oxygen, Partial Pressure, Blood-phase, Indwelling
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCE Analyzer, Gas, Oxygen, Partial Pressure, Blood-phase, Indwelling

All 22
Devices cleared under the same product code (CCE) and FDA review panel - the closest regulatory comparables to K832793.
OXYGEN MONITOR OM-100 & OXYGEN PROBE OP-100
K853786 · American Bentley · Oct 1985
INTRAVASCULAR BLOOD GAS SYSTEM
K843912 · Cardiovascular Devices, Inc. · Jan 1985
ARTERIAL BLOOD GAS INTERPRETATION PROG
K840102 · M. D. Software, Inc. · Feb 1984
VENOUS OXYGEN PROBE
K811071 · G.D. Searle and Co. · May 1981
MONITOR, PO2, INTRAVASCULAR
K781271 · Roche Medical Electronics, Inc. · Oct 1978
SEARLE NEONATAL OXYGEN PROBE
K780850 · Will Ross Co. · Aug 1978